Insider and congress filings
Labcorp Holdings Inc. (LH)
About Labcorp Holdings Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Chief executive
- Adam H. Schechter
- Employees
- 71,000
- Listed since
- Mar 29, 1990
- Market value
- $26.3B
- Price to earnings
- 26.4
- Earnings per share
- $12.27
- Dividend yield
- 0.90%
Earnings
6 reported quarters · next on Oct 27, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $4.99 | $4.78 | $3.7B | $3.7B | EPS beatRevenue in line |
| Q1 FY2026reported Apr 30, 2026 | $4.25 | $4.11 | $3.5B | $3.5B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 17, 2026 | $4.07 | $3.95 | $3.5B | $3.6B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 28, 2025 | $4.18 | $4.13 | $3.6B | $3.6B | EPS in lineRevenue in line |
| Q2 FY2025reported Jul 24, 2025 | $4.35 | $4.17 | $3.5B | $3.5B | EPS beatRevenue in line |
| Q1 FY2025reported Apr 29, 2025 | $3.84 | $3.74 | $3.3B | $3.4B | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 10, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| ADAM H. SCHECHTERPresident and Chief Executive Officer | $1.4M | $11.4M | $5.5M | $18.3M |
| JULIA A. WANGExecutive Vice President and Chief Financial Officer | $738K | $2.7M | $1.6M | $5.0M |
| BRIAN J. CAVENEYExecutive Vice President and President, Early Developm | $748K | $2.3M | $1.3M | $4.4M |
| MEGAN D. BAILEYExecutive Vice President and President, Central Labora | $569K | $1.3M | $890K | $2.7M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $1.8B | 6,574,261 | +2.0% | 8.05% |
| Vanguard Capital Management LLC | $1.5B | 5,362,254 | -0.3% | 6.56% |
| Victory Capital Management Inc | $1.4B | 4,837,573 | +4.5% | 5.92% |
| State Street Corp | $1.1B | 3,907,656 | +1.2% | 4.78% |
| Vanguard Portfolio Management LLC | $1.0B | 3,678,798 | -0.1% | 4.50% |
| Boston Partners | $854.2M | 3,051,690 | +28.8% | 3.74% |
| Allspring Global Investments Holdings, LLC | $635.0M | 2,236,957 | +0.5% | 2.74% |
| Geode Capital Management, LLC | $610.4M | 2,188,890 | +0.1% | 2.68% |
| Select Equity Group, L.P. | $554.9M | 1,981,948 | -8.9% | 2.43% |
| FMR LLC | $533.4M | 1,904,870 | +47.8% | 2.33% |
| Morgan Stanley | $450.6M | 1,609,447 | +7.4% | 1.97% |
| Dimensional Fund Advisors LP | $382.8M | 1,367,166 | +2.6% | 1.67% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
16 filings of 313 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Kerrii B. AndersonDirector | Sold | 3,000 | $318.02 | $954K | Aug 17, 2026 | 1d |
| Adam H. SchechterPresident & CEO | Sold | 4,669 | $320.37 | $1.5M | Aug 11, 2026 | 1d |
| Amy B. SummyEVP, Chief Marketing Officer | Sold | 924 | $306.74 | $283K | Aug 4, 2026 | 2d |
| Peter J. WilkinsonSVP, Chief Accounting Officer | Sold · 2 lines | 1,420 | $309.23 | $439K | Aug 3, 2026 | 2d |
| Bryan T. VaughnEVP and President, Diagnostics | Sold | 234 | $286.19 | $67K | Jul 2, 2026 | 4d |
| Kathryn W. KyleEVP, Chief Legal Officer | Sold | 92 | $286.19 | $26K | Jul 2, 2026 | 4d |
| Kathryn W. KyleEVP, Chief Legal Officer | Sold | 762 | $263.89 | $201K | Jun 8, 2026 | 2d |
| Adam H. SchechterPresident & CEO | Sold | 5,903 | $254.50 | $1.5M | May 11, 2026 | 2d |
| Jonathan C. MeltzerEVP, Operations | Sold | 839 | $267.05 | $224K | Mar 27, 2026 | 3d |
| Peter J. WilkinsonSVP, Chief Accounting Officer | Sold | 1,633 | $267.05 | $436K | Mar 27, 2026 | 3d |
| Adam H. SchechterPresident & CEO | Sold | 8,705 | $279.96 | $2.4M | Mar 3, 2026 | 2d |
| Sandra D. van der VaartEVP, Corporate Affairs | Sold | 548 | $284.91 | $156K | Feb 27, 2026 | 4d |
| Brian J. CaveneyEVP, Pres of Ed, CMO & CSO | Sold | 1,500 | $286.31 | $429K | Feb 24, 2026 | 2d |
| Peter J. WilkinsonSVP, Chief Accounting Officer | Sold | 666 | $277.94 | $185K | Feb 19, 2026 | 4d |
| Adam H. SchechterPresident & CEO | Sold | 5,273 | $284.38 | $1.5M | Feb 11, 2026 | 2d |
| Jonathan C. MeltzerEVP, Operations | Sold | 87 | $290.42 | $25K | Feb 12, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in LH
20 disclosures of 77 on record · median 16d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +21.5%S&P +20.2% · vs S&P 500 +1.3% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +16.0%S&P +2.5% · vs S&P 500 +13.5% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +28.2%S&P +3.2% · vs S&P 500 +25.1% | May 15, 2026 | Jun 9, 2026 | 25d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +10.8%S&P +10.3% · vs S&P 500 +0.5% | Feb 11, 2026 | Mar 10, 2026 | 27d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +16.3%S&P +11.3% · vs S&P 500 +5.0% | Feb 4, 2026 | Mar 10, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +28.2%S&P +9.6% · vs S&P 500 +18.6% | Jan 12, 2026 | Feb 6, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +19.0%S&P +9.8% · vs S&P 500 +9.2% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +19.8%S&P +9.8% · vs S&P 500 +10.1% | Jan 28, 2026 | Feb 2, 2026 | 5d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +22.9%S&P +14.7% · vs S&P 500 +8.2% | Nov 17, 2025 | Dec 8, 2025 | 21d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +16.5%S&P +11.3% · vs S&P 500 +5.2% | Oct 27, 2025 | Nov 6, 2025 | 10d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +29.4%S&P +11.1% · vs S&P 500 +18.4% | Oct 29, 2025 | Nov 4, 2025 | 6d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +26.5%S&P +12.0% · vs S&P 500 +14.5% | Oct 31, 2025 | Nov 4, 2025 | 4d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +23.2%S&P +23.6% · vs S&P 500 -0.4% | Jun 27, 2025 | Jul 9, 2025 | 12d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +23.0%S&P +26.7% · vs S&P 500 -3.6% | Jun 23, 2025 | Jul 9, 2025 | 16d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +30.0%S&P +29.7% · vs S&P 500 +0.3% | May 28, 2025 | Jun 10, 2025 | 13d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | +30.4%S&P +29.1% · vs S&P 500 +1.3% | May 15, 2025 | May 31, 2025 | 16d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +47.5%S&P +53.5% · vs S&P 500 -5.9% | Apr 8, 2025 | May 8, 2025 | 30d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +38.0%S&P +36.4% · vs S&P 500 +1.6% | Mar 31, 2025 | Apr 7, 2025 | 7d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | +27.0%S&P +28.3% · vs S&P 500 -1.3% | Feb 25, 2025 | Mar 27, 2025 | 30d |
| April McClain DelaneyDependent child | Stock | Purchase | $1,001 - $15,000 | +28.5%S&P +26.3% · vs S&P 500 +2.1% | Feb 5, 2025 | Mar 20, 2025 | 43d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
4 members · estimate, as of Sep 10, 20264 members report a position (estimated). The largest estimated position is in the $100,001 - $250,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| April McClain Delaney | Democrat · House | $100,001 - $250,000 | 4.1% |
| J. French Hill | Republican · House | $50,001 - $100,000 | 0.6% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $1,001 - $15,000 | <0.1% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Bryan T. VaughnEVP and President, Diagnostics | Stock award | 1,500 | Sep 1, 2026 |
| Brian J. CaveneyEVP, Pres of Bls, CMO & CSO | Stock award | 3,000 | Sep 1, 2026 |
| Jonathan C. MeltzerEVP, COO | Stock award | 900 | Sep 1, 2026 |
| Akinbolade OyegunwaEVP, CIO & CTO | Stock award | 750 | Sep 1, 2026 |
| Peter J. WilkinsonSVP, Chief Accounting Officer | Option exercise | 1,338 | Aug 3, 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | Option exercise | 256 | Jul 1, 2026 |
| Bryan T. VaughnEVP and President, Diagnostics | Tax withholding | 93 | Jul 1, 2026 |
| Bryan T. VaughnEVP and President, Diagnostics | Option exercise | 327 | Jul 1, 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | Tax withholding | 73 | Jul 1, 2026 |
| Peter J. WilkinsonSVP, Chief Accounting Officer | Stock award | 2,388 | Mar 26, 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | Tax withholding | 451 | Mar 26, 2026 |
| Brian J. CaveneyEVP, Pres of Ed, CMO & CSO | Tax withholding | 4,905 | Mar 26, 2026 |
| Brian J. CaveneyEVP, Pres of Ed, CMO & CSO | Stock award | 11,290 | Mar 26, 2026 |
| Kathryn W. KyleEVP, Chief Legal Officer | Stock award | 1,584 | Mar 26, 2026 |
| Mark S. SchroederEVP, Pres Diagnostics & COO | Tax withholding | 6,068 | Mar 26, 2026 |
| Mark S. SchroederEVP, Pres Diagnostics & COO | Stock award | 12,272 | Mar 26, 2026 |
| Anita Z. GrahamEVP, CHRO | Tax withholding | 2,879 | Mar 26, 2026 |
| Anita Z. GrahamEVP, CHRO | Stock award | 6,604 | Mar 26, 2026 |
| Adam H. SchechterPresident & CEO | Tax withholding | 26,106 | Mar 26, 2026 |
| Adam H. SchechterPresident & CEO | Stock award | 58,470 | Mar 26, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling LH?
Across the 16 most recent open-market filings shown here, 0 were purchases and 16 were sales.
Which members of Congress have traded LH?
Alan Armstrong, Ro Khanna, April McClain Delaney, Robert Bresnahan, Gilbert Ray Cisneros, Jr. disclosed LH transactions in the filings shown here.
Which members of Congress hold LH?
4 members of Congress report a position in LH in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to April McClain Delaney, J. French Hill and Gilbert Ray Cisneros, Jr.. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is LH in the S&P 500 or the Nasdaq 100?
Labcorp Holdings Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are LH trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 16 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.